Angiosarcoma: Clinical Trials

5 trials for Angiosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5

Follow Angiosarcoma: new trials by email Literature Review of Angiosarcoma trials Research Report on Angiosarcoma

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Propranolol in Angiosarcoma
Propranolol - Angiosarcoma
Phase 2CompletedThe Netherlands Cancer Institute142019-12-272023-11-22
Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)
Eribulin - Angiosarcoma, Epithelioid Hemangioendothelioma
Phase 2CompletedMassachusetts General Hospital132018-01-182026-08-28
Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
Dexrazoxane, Doxorubicin - Sarcoma, Soft Tissue, Soft Tissue Sarcoma
Phase 2CompletedWashington University School of Medicine732016-02-222023-11-07
Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas
Paclitaxel, Bevacizumab - Angiosarcoma
Phase 2CompletedCentre Oscar Lambret702010-09-102026-03-13
Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes
gemcitabine, docetaxel, bevacizumab - Sarcoma, Leiomyosarcoma
Phase 2CompletedMemorial Sloan Kettering Cancer Center472009-04-012016-01-25

Narrower conditions

Hemangiosarcoma (5)  ·  Leiomyosarcoma (2)  ·  Sarcoma (2)  ·  Dermatofibrosarcoma (1)  ·  Fibrosarcoma (1)  ·  Hemangioendothelioma, Epithelioid (1)  ·  Histiocytoma (1)  ·  Histiocytoma, Malignant Fibrous (1)  ·  Liposarcoma (1)  ·  Neurofibrosarcoma (1)  ·  Sarcoma, Synovial (1)

Broader conditions

Neoplasms (5)  ·  Neoplasms by Histologic Type (5)  ·  Neoplasms, Connective and Soft Tissue (5)  ·  Neoplasms, Vascular Tissue (5)  ·  Sarcoma (3)  ·  Neoplasms, Connective Tissue (2)  ·  Neoplasms, Fibrous Tissue (2)  ·  Neoplasms, Muscle Tissue (2)  ·  Hemangioendothelioma (1)  ·  Hemangioma (1)  ·  Histiocytoma (1)  ·  Neoplasms, Adipose Tissue (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Nerve Sheath Neoplasms (1)  ·  Nervous System Diseases (1)

Interventions

Bevacizumab (2)  ·  Dexrazoxane (1)  ·  Docetaxel (1)  ·  Doxorubicin (1)  ·  Gemcitabine (1)  ·  Paclitaxel (1)  ·  Propranolol (1)  ·  Razoxane (1)  ·  eribulin (1)

Sponsors

Centre Oscar Lambret (1)  ·  Massachusetts General Hospital (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  The Netherlands Cancer Institute (1)  ·  Washington University School of Medicine (1)

Countries

United States (3)  ·  France (1)  ·  Netherlands (1)

Top investigators

Brian A Van Tine, M.D., Ph.D. (1)  ·  Gregory Cote, MD, PhD (1)  ·  Neeltje Steeghs, MD PhD (1)  ·  William Tap, MD (1)  ·  Winan van Houdt, MD PhD (1)

Results publications

PMID 30305054

NIH funding

2009 (1)